Benzinga | Oct 8, 2020 07:04AM EDT

HC Wainwright & Co. Maintains Buy on Corbus Pharmaceuticals, Lowers Price Target to $3

HC Wainwright & Co. maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and lowers the price target from $6 to $3.